Cargando…

Modification of the diabetes prevention program for the treatment of nonalcoholic fatty liver disease: A pilot study

OBJECTIVE: The Diabetes Prevention Program (DPP) is the gold standard lifestyle modification program that reduces incident type 2 diabetes mellitus. Patients with prediabetes and patients with non‐alcoholic fatty liver disease (NAFLD) often share metabolic features; we hypothesized that the DPP coul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hershman, Melissa, Torbjornsen, Karen, Pang, Daniel, Wyatt, Brooke, Dieterich, Douglas T., Perumalswami, Ponni V., Branch, Andrea D., Dinani, Amreen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242246/ https://www.ncbi.nlm.nih.gov/pubmed/37287520 http://dx.doi.org/10.1002/osp4.637

Ejemplares similares

A Digital Case‐Finding Algorithm for Diagnosed but Untreated Hepatitis C: A Tool for Increasing Linkage to Treatment and Cure
por: Wyatt, Brooke, et al.
Publicado: (2021)

Automated phenotyping of patients with non-alcoholic fatty liver disease reveals clinically relevant disease subtypes
por: Vandromme, Maxence, et al.
Publicado: (2020)

Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma
por: Hannaford, Alisse, et al.
Publicado: (2017)

Environmental exposures are important risk factors for advanced liver fibrosis in African American adults
por: Ma, Ning, et al.
Publicado: (2023)

Hepatocellular carcinoma surveillance, incidence, and tumor doubling times in patients cured of hepatitis C
por: Perumalswami, Ponni V., et al.
Publicado: (2022)

Liver Stiffness Decreases Rapidly in Response to Successful Hepatitis C Treatment and Then Plateaus
por: Chekuri, Sweta, et al.
Publicado: (2016)

Innovations in Hepatitis C Screening and Treatment
por: Patel, Arpan A., et al.
Publicado: (2020)

COVID-19 in Liver Transplant Recipients: An Initial Experience From the US Epicenter
por: Lee, Brian T., et al.
Publicado: (2020)

Roles of RNA m6A modification in nonalcoholic fatty liver disease
por: Tan, Jian, et al.
Publicado: (2023)

HBV screening among West Africans living in the US: Influences of stigma, health literacy, and self-efficacy
por: Perumalswami, Ponni V, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Acceleration training for managing nonalcoholic fatty liver disease: a pilot study
por: Oh, Sechang, et al.
Publicado: (2014)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Long-Term Effects of Metformin and Lifestyle Modification on Nonalcoholic Fatty Liver Disease Obese Adolescents
por: Tock, Lian, et al.
Publicado: (2010)

Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins
por: Pirola, Carlos J., et al.
Publicado: (2015)

Role of diet and lifestyle modification in the management of nonalcoholic fatty liver disease and type 2 diabetes
por: Prabhakar, Orsu, et al.
Publicado: (2020)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Sirtuins and nonalcoholic fatty liver disease
por: Nassir, Fatiha, et al.
Publicado: (2016)

History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease and diabetes
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease
por: Pang, Lijun, et al.
Publicado: (2018)

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
por: Younossi, Zobair M., et al.
Publicado: (2017)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Eggs, Worms, or Both? Chronic Active Schistosomiasis Presenting as Cirrhosis and Colonic Polyps
por: Karim, Gres, et al.
Publicado: (2022)

Pancreatic β-Cell Dysfunction Is Associated with Nonalcoholic Fatty Liver Disease
por: Chen, Xu, et al.
Publicado: (2021)

Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome
por: Castillo-Castro, Carolina, et al.
Publicado: (2021)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Methotrexate-Associated Nonalcoholic Fatty Liver Disease with Transaminitis in Rheumatoid Arthritis
por: Sakthiswary, Rajalingham, et al.
Publicado: (2014)

Morphological and metabolic determinants of nonalcoholic fatty liver disease in obese youth: a pilot study
por: Monteiro, Paula A, et al.
Publicado: (2013)

A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease
por: Vos, Miriam B., et al.
Publicado: (2018)

Role of bioactive fatty acids in nonalcoholic fatty liver disease
por: Juárez-Hernández, Eva, et al.
Publicado: (2016)

Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Caussy, Cyrielle, et al.
Publicado: (2020)

Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
por: Ulasoglu, Celal, et al.
Publicado: (2021)

The Effect of a Lifestyle Modification Education on Adiposity Measures in Overweight and Obese Nonalcoholic Fatty Liver Disease Patients
por: Arab, Arman, et al.
Publicado: (2017)

Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis
por: Yoshioka, Naoki, et al.
Publicado: (2020)

Telementoring of primary care providers delivering hepatitis C treatment in New York City: Results from Project INSPIRE
por: Teixeira, Paul A., et al.
Publicado: (2018)

Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease
por: Obika, Mikako, et al.
Publicado: (2012)

Nuclear Receptors in Nonalcoholic Fatty Liver Disease
por: López-Velázquez, Jorge A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_pq7aagprn60rqtkrb9c121i66v